100 related articles for article (PubMed ID: 28512893)
21. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 3 different postimplant dosimetry methods following permanent 125I prostate seed brachytherapy.
Marcu LG; Gowda R
Med Dosim; 2013; 38(3):309-14. PubMed ID: 23611630
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy.
Wang Y; Nasser NJ; Borg J; Saibishkumar EP
J Contemp Brachytherapy; 2015 Jun; 7(3):203-10. PubMed ID: 26207108
[TBL] [Abstract][Full Text] [Related]
24. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy.
Crook J; Patil N; Ma C; McLean M; Borg J
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1079-84. PubMed ID: 19879700
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial.
Kaplan ID; Meskell PM; Lieberfarb M; Saltzman B; Berg S; Holupka EJ
Brachytherapy; 2004; 3(1):7-9. PubMed ID: 15110307
[TBL] [Abstract][Full Text] [Related]
27. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
[TBL] [Abstract][Full Text] [Related]
28. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
Crook J; McLean M; Yeung I; Williams T; Lockwood G
Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
[TBL] [Abstract][Full Text] [Related]
29. Post-implant computed tomography-magnetic resonance prostate image registration using feature line parallelization and normalized mutual information.
Vidakovic S; Jans HS; Alexander A; Sloboda RS
J Appl Clin Med Phys; 2006 Jul; 8(1):21-32. PubMed ID: 17592452
[TBL] [Abstract][Full Text] [Related]
30. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
31. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
32. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of intraoperative magnetic resonance imaging/ultrasound fusion optimization for low-dose-rate prostate brachytherapy.
Abel S; Renz P; Gayou O; Tang J; Werts ED; Trombetta M
J Contemp Brachytherapy; 2017 Aug; 9(4):309-315. PubMed ID: 28951749
[TBL] [Abstract][Full Text] [Related]
34. Sci-Sat AM(2): Brachy-07: Tomosynthesis-based seed reconstruction in LDR prostate brachytherapy: A clinical study.
Brunet-Benkhoucha M; Verhaegen F; Lassalle S; Béliveau-Nadeau D; Reniers B; Donath D; Taussky D; Carrier JF
Med Phys; 2008 Jul; 35(7Part3):3417. PubMed ID: 28512882
[TBL] [Abstract][Full Text] [Related]
35. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
[TBL] [Abstract][Full Text] [Related]
36. Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software.
Siebert FA; Kohr P; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):96-101. PubMed ID: 16447016
[TBL] [Abstract][Full Text] [Related]
37. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
38. MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
Polo A; Cattani F; Vavassori A; Origgi D; Villa G; Marsiglia H; Bellomi M; Tosi G; De Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1572-9. PubMed ID: 15590189
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
[TBL] [Abstract][Full Text] [Related]
40. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
